TNFRSF11B and head and neck squamous cell carcinoma: OPG inhibited NF-κB activity (after 24 h, Fig. 4b) and integrin α2 expression (after 72 h, Fig. 4c) in RANKL-expressing HNSCC cells by approximately 30%, which was comparable to the control cells.